Australia's Inoviq sees best day in 2 weeks on Brazil patent

Inoviq

23/02/2022 03:13

** Medical diagnostics company's shares  IIQ.AX  rise as
much as 5.7% to A$1.02, on track for best session since Feb. 7
if gains hold
    ** Company says Brazilian patent https://www.asx.com.au/asxpdf/20220223/pdf/4568w0fzgwbv00.pdf
 covering use of BARD1 isoforms in lung and colorectal cancer
was issued by the National Institute of Industrial Property
    ** IIQ says patent provides IP protection for a potential
BARD1 antibody test for lung cancer in Brazil
    ** Company's shares down ~19.3% so far this year, as of last
close

 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))